Company / Revenue
NP Life Sciences Health Industry Group Inc. Revenue History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$164.6K
FY2023
5-year range
$15.0K / $164.6K
FY2019-FY2023
Trend
+61.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 3 consecutive years, from $15,000 in FY2020 to $164,621 in FY2023.
Based on SEC 10-K filings.
$164,621 in FY2023 with a 3-year CAGR of +122.2%.
Improved from $34,992 to $164,621 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +122.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NP Life Sciences Health Industry Group Inc.'s revenue has grown for 3 consecutive years.
- 3-year CAGR of +122.2%, indicating consistent growth.
- In FY2023, revenue increased 61.4% year-over-year.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $164.6K | +61.4% |
| FY2022 | $102.0K | +191.5% |
| FY2021 | $35.0K | +133.3% |
| FY2020 | $15.0K | -65.1% |
| FY2019 | $43.0K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026